Electronic portal imaging device-based three-dimensional volumetric dosimetry for intensity-modulated radiotherapy pretreatment quality assurance

Autor: Manikandan Arjunan, Sureka Chandra Sekaran, Biplab Sarkar, Saran Kumar Manavalan
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Journal of Medical Physics, Vol 44, Iss 3, Pp 176-184 (2019)
Druh dokumentu: article
ISSN: 0971-6203
1998-3913
DOI: 10.4103/jmp.JMP_42_19
Popis: Aim: This study aimed at evaluating the efficacy of treatment planning system (TPS)-based heterogeneity correction for two- and three-dimensional (2D and 3D) electronic portal imaging device (EPID)-based pretreatment dose verification. An experiment was conducted on the EPID back-projection technique and intensity-modulated radiotherapy (IMRT). Materials and Methods: Treatment plans were delivered in EPID without a patient to obtain the fluence pattern (FEPID). A heterogeneity correction plane (Fhet) for an open beam of 30 cm × 30 cm was extracted from the TPS. The heterogeneity-corrected measured fluence is developed by matrix element multiplication (FResultant= FEPID× Fhet). Further planes were summed to develop a 3D dose distribution and exported to the TPS. Dose verifications for 2D and 3D were carried out with the corresponding TPS values using 2D gamma analysis (ɣ) and dose volume histogram (DVH) comparison, respectively. Totally, 33 patients (17 head–neck and 16 thorax cases) were evaluated in this study. Results: The head–neck and thorax plans show a 3-mm-distance to agreement (DTA) 3% DD gamma passing of 96.3% ± 2.0% and 95.4% ± 1.8% points, respectively, between FTPS and FResultant. The comparison of the uncorrected measured fluence (FEPID) with FTPS reveals a gamma passing of 82.2% ± 7.3% and 80.4% ± 8.6% for head–neck and thorax cases, respectively. A total of 87 out of the 102 head–neck and thorax beams exhibit a planner gamma passing of 97.6% ± 2.1%. In the 3D-DVH comparison of thorax and head–neck cases, D5% for planning target volume were −0.5% ± 2.2% and −2.1% ± 3.5%, respectively; D95% varies as 1.0% ± 2.7% and 1.4% ± 1.1% between TPS calculated and heterogeneity-corrected-EPID-based dose reconstruction. Conclusion: The novel TPS-based heterogeneity correction can improve the 2D and 3D EPID-based back projection technique. Structures with large heterogeneities can also be handled using the proposed technique.
Databáze: Directory of Open Access Journals
Externí odkaz: